Company News

Sabinsa’s Macumax Formula Demonstrates Vision Health Benefits

Results were reported in a recent open-label pilot study.

Author Image

By: Charlie Sternberg

Associate Editor

In a clinical trial on subjects diagnosed with age-related macular degeneration (AMD), Sabinsa’s proprietary formulation Macumax was shown to have vision health benefits. The study, An Open-Label Pilot Study on Macumax Supplementation for Dry-Type Age-Related Macular Degeneration authored by Muhammed Majeed, Shaheen Majeed and Kalyanam Nagabhushanam, was published in the Journal of Medicinal Food (ahead of print doi.org/10.1089/jmf.2020.0097).   Macumax contains xanthophyll carotenoids Lutein an...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters